Comments on: Inferior Vena Cava Filters in Pregnancy: A Systematic Review

Abdul-Rahim, Osama; Weinstein, Jeffrey L.; Brady, Paul S.

doi:10.1016/j.jvir.2016.05.021

Cited by 5 publications

(3 citation statements)

References 1 publication

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Of the five cases and four case series reported, only five women had progression of VTE despite adequate anticoagulant treatment or contraindications to AC treatment 27–35. Estimated time since filter insertion was more than 30 days with a maximum of 287 days 32.…”

Section: Discussionmentioning

confidence: 94%

Acute inferior vena cava thromboembolism in pregnancy

Bilyalova,

Iskalieva,

Baibusunova

et al. 2024

BMJ Case Rep

View full text Add to dashboard Cite

A multigravida in her late 20s was diagnosed with inferior vena cava thrombosis (IVCT) and PE at 26 weeks of pregnancy after a routine prenatal care visit. The patient denied any diseases that could cause IVCT, as well as the presence of any symptoms. Progressive thrombocytopenia was diagnosed in the period until the implantation of the inferior vena cava filter (IVCF). Due to a rupture of foetal membranes and chorioamnionitis, labour was induced at 32 weeks of pregnancy. The IVCF remained in place and anticoagulants were continued through the postpartum period for up to 6 months.

show abstract

Section: Discussionmentioning

confidence: 94%

Acute inferior vena cava thromboembolism in pregnancy

Bilyalova,

Iskalieva,

Baibusunova

et al. 2024

BMJ Case Rep

View full text Add to dashboard Cite

show abstract

“…With fluoroscopy, it is estimated at ~70 mSv [51], and likely not below in pregnant women. Given the threshold of <100 mSv associated with fetal radiological complications [50], some advocate for the placement of the IVC filter with intravascular US instead of fluoroscopy [52].…”

Section: Vena Cava Filtersmentioning

confidence: 99%

Management of high-risk pulmonary embolism in pregnancy

Blondon¹,

Tejada

Glauser³

et al. 2021

Thrombosis Research

View full text Add to dashboard Cite

Pregnancy-associated high-risk pulmonary embolism (PE) is among the most frequent causes of maternal mortality in the Western world, by causing hemodynamic instability and circulatory failure through a large thrombotic pulmonary obstruction. The very challenging management of these dramatic situations comprises the need to quickly select a therapy of pulmonary reperfusion or hemodynamic replacement, while taking into account both maternal and fetal risks. In this review, we discuss the role of risk stratification in pregnancyassociated PE and the available evidence to support the use of thrombolysis, catheter-directed thrombectomy/ thrombolysis, surgical embolectomy and extracorporeal membrane oxygenation. Despite the lack of comparative studies and solid evidence, most reported cases of high-risk pregnancy-associated PE have been treated with thrombolysis, with high maternal and fetal survivals, and thrombolysis is suggested by guidelines in lifethreatening PE. For women in the peripartum and early post-partum period, non-fibrinolytic treatments may be preferred as a first-line treatment, if available, because of the particularly high bleeding risk. In all cases, pregnancy-associated high-risk PE requires a multidisciplinary approach involving PE response teams and obstetricians.

show abstract

“…Intravascular US-guided placement None Successful Infrarenal Withholding of AC before delivery Planned CS Before delivery Abdul-Rahim et al 1 (2016)…”

Section: Reference (Year)mentioning

confidence: 99%